Symtomax CBD ORAL TAB: innovative delivery for cannabinoids

Over the past few years the global market for cannabidiol (CBD) has expanded rapidly with growing demand for CBD products expected to continue through 2022 transforming this market into a mega industry of its own. According to the latest research by the Global Wellness Institute (GWI), the worldwide wellness market grew 12.9% from a $3.72 […]

Continue reading
gcanrx symtomax

GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS ACROSS EUROPE, THE MIDDLE EAST AND AFRICA

BALTIMORE, MD – May 7, 2019 — Greater Cannabis Company (OTC: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with European-based Symtomax, a licensed group on medical cannabis cultivation, research and distribution with over 40 years of […]

Continue reading